THURSDAY, May 5, 2016 (HealthDay News) — The U.S. Food and Drug Administration said Thursday that it is banning the sale of e-cigarettes to minors, as part of its long-awaited plan to extend the agency’s regulatory powers across all tobacco products.
The new rules would halt the sale of e-cigarettes and any other tobacco product to anyone younger than 18.
The regulations also would require photo IDs to buy e-cigarettes, and ban retailers from handing out free samples or selling them in all-ages vending machines.
The rules will go into effect in 90 days, the FDA said, and also cover other alternative forms of tobacco like cigars, hookah tobacco and pipe tobacco.
Electronic cigarettes are battery-operated devices designed to create an aerosol that delivers nicotine, flavor and other chemicals when inhaled by the user. Manufacturers have marketed the products as a way to help smokers quit cigarettes, but opponents contend that the nicotine-laden e-cigarettes actually encourage people — especially vulnerable teens — to pick up the smoking habit.
The FDA action earned universal praise from medical associations, which have been concerned that e-cigarettes serve as a gateway drug to draw teenagers into a lifetime of smoking addiction.
“Youth use e-cigarettes more than any other tobacco product on the market today, serving as an entry point to more traditional tobacco products and placing kids at risk to the harms and addiction of nicotine and other tobacco products,” said Harold Wimmer, national president and CEO of the American Lung Association. “Ending the tobacco epidemic is more urgent than ever, and can only happen if the FDA acts aggressively and broadly to protect all Americans from all tobacco products.”
Until now, e-cigarettes and other alternative tobacco products have gone unregulated by the FDA, despite a 2009 law that granted the agency the authority to govern any tobacco sold in the United States.
Manufacturers of e-cigarettes also will be required to submit new and existing products to the FDA for review and evaluation, unless the product was sold prior to Feb. 15, 2007.
That cut-off date means that 99 percent of all e-cigarette and “vaping” products now on the market will have to be submitted for FDA review, according to a statement by the Smoke-Free Alternatives Trade Association.
The FDA anticipates that existing e-cigarette brands will have at least three more regulation-free years on the market — two years while manufacturers prepare their product application and another year for FDA review.
The new regulations bring e-cigarettes and other alternative tobacco products in line with the FDA rules that already govern traditional cigarettes, the agency said. As a result, e-cigarette manufacturers will have to:
- Report all ingredients, including potentially harmful ones.
- Place health warnings on product packages and advertisements.
- Refrain from selling their products as “low-risk” tobacco alternatives unless specifically authorized by the FDA.
The American Academy of Pediatrics praised the new FDA rules, but criticized the agency for not going further.
“FDA passed up critical opportunities in this rule by failing to prohibit the sale of tobacco products coming in flavors like cotton candy, gummy bear and grape, or to prevent marketing tactics that target children,” said AAP President Dr. Benard Dreyer.
E-cigarette trade associations condemned the new regulations.
“If the FDA’s rule is not changed by Congress or the courts, thousands of small businesses will close in two to three years,” said Gregory Conley, president of the American Vaping Association. “Tens of thousands of jobs will be lost and consumer choice will be annihilated. Absurdly, ex-smokers will face the prospect of having to purchase products that help them remain smoke-free on the black market.”
The Smoke-Free Alternatives Trade Association stated: “Today’s final rule pulls the rug out from the 9 million smokers who have switched to vaping, putting them in jeopardy of returning back to smoking, which kills 480,000 Americans each year and costs the U.S. more than $300 billion in annual health care expenses. These new regulations create an enormously cost-prohibitive regulatory process for manufacturers to market their products to adult smokers and vapers,” crippling a “multi-billion job-creating industry.”
For more on the FDA ruling, click here.